RSS

Novartis Pharmaceuticals

Novartis Pharmaceuticals, in cooperation with the US Consumer Product Safety Commission (CPSC) and the Food and Drug Administration (FDA), has voluntarily implemented a corrective action plan concerning Zofran and Entresto packages in the US. more

News

Novartis has focussed its pharmaceutical division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology, that will together function as the Innovative Medicine Division at Novartis more

News